Neonatology 2 – High-Risk Pregnancy & Common Neonatal Problems

High-Risk Pregnancy: Definition & Factors

  • Any pregnancy in which maternal and/or fetal conditions may culminate in an adverse perinatal outcome.

  • Identification may occur ante- or intrapartum.

Antepartum Factors Associated with Neonatal Depression

  • Pre-term labor and delivery

  • PROM (premature rupture of membranes)

  • Multiple gestation

  • Chronic pregnancy-induced hypertension (preeclampsia/eclampsia)

  • Maternal diabetes

  • Maternal substance abuse

  • Vaginal bleeding, placenta previa, abruptio placentae

  • Lack/late/limited prenatal care

Prenatal Disturbances

  • Maternal infections: GBS, Herpes, Rubella

  • ↓ Fetal activity

  • Maternal anemia or Rh iso-immunization

  • Oligo- / Poly-hydramnios

  • Previous fetal/neonatal death

  • Congenital anomalies

  • Maternal systemic disease (CVS, thyroid, neurologic, SLE)

  • Drug therapy: lithium, beta-blockers, MgSO4MgSO_4

  • Environmental toxins/teratogens

Intrapartum Risk Factors

  • Maternal/fetal infection

  • Prolapsed cord, prolonged labor, maternal sedation

  • Operative/assisted delivery; breech/abnormal presentation

  • Meconium-stained amniotic fluid

  • PROM >18 h

  • Abnormal FHR patterns

Routine/Selective Screening in High-Risk Pregnancy

  • Diabetes, genetic conditions, congenital anomalies → early recognition/intervention

Pre-Term Labor (PTL)

  • Onset of labor <37 weeks GA (WHO: 203720−37 weeks).

  • PTL → 4050%40−50\% of pre-term births; remainder from PPROM or indicated pre-term delivery.

Major Risk Factors

  • Low socioeconomic status, smoking, substance abuse, poor nutrition

  • Inadequate/absent prenatal care

  • History of PTL/delivery, uterine/cervical anomalies (DES), myomata

  • Maternal HTN, preeclampsia, diabetes

  • Multiple gestation, amniotic fluid disorders, vaginal bleeding, infection

Pathogenesis (Spontaneous, Isolated PTL)

  • Often occult upper‐genital-tract infection → decidual activation

  • Inflammatory cytokines IL-1, IL-6, TNF-α in AF → ↑ PGE<em>2<em>2/PGF</em>2α</em>{2α} → uterine contractions & cervical ripening

Treatment

  • Cervical cerclage for structural incompetence

  • Tocolytics: β-mimetics (terbutaline, ritodrine), MgSO4MgSO_4, indomethacin

  • Antibiotics when infection/PPROM suspected

Preeclampsia/Eclampsia

  • New-onset gestational HTN ++ proteinuria (± edema) after 2020 wk.

  • Incidence: 8%\approx8\% pregnancies; major cause perinatal M&M.

  • Pathophysiology: uteroplacental ischemia, RAAS activation; exact etiology unknown.

  • Predisposition: primiparity, age extremes, genetics, twins, DM, non-immune hydrops.

Maternal Management
  • Definitive Rx = delivery.

  • Balance fetal immaturity vs maternal status → antihypertensives, MgSO4MgSO_4 seizure prophylaxis.

Fetal Consequences
  • Prematurity → dominant driver of morbidity.

  • Uteroplacental insufficiency, abruptio placentae, IUGR common.

  • Curiously ↓ risk of cerebral palsy vs other causes of prematurity.

Diabetes in Pregnancy

  • Types: Type 1 (absolute insulin lack), Type 2 (insulin resistance), Gestational.

  • Modified White Classification: A1 = diet controlled; A2 = insulin required.

  • Gestational DM accounts for 8090%80−90\% of diabetic pregnancies (total prevalence 35%3−5\%).

  • Mechanism: normal 60%\approx60\% ↓ insulin sensitivity; some women cannot compensate.

Screening & Targets

  • Screen 242824−28 wk GA.

  • Maintain glucose 6012060−120 mg/dL → marked ↓ fetal/neonatal complications.

Fetal-Neonatal Complications

A. Congenital anomalies (Type 1): sacral agenesis, NTD, cardiac (TGA, VSD, hypertrophic CMP).
B. Macrosomia: 2545%25−45\% incidence → birth trauma, asphyxia, neonatal hypoglycemia.
C. Polyhydramnios.
D. Hypoxia → polycythemia.
E. Delayed lung maturation → ↑ RDS.

Neonatal Management

  • Screen/tx hypoglycemia, assess trauma, look for respiratory distress (TTNB, RDS).

Maternal Substance Abuse

  • Present in 56%5−6\% pregnancies; often co-morbid with STIs, TB, hepatitis, malnutrition.

Agents & Outcomes

  • Alcohol → FAS: microcephaly, MR, facial dysmorphisms, cardiac defects; withdrawal rare.

  • Heroin → stillbirth, pre-term, SGA; NAS in 5075%50−75\% within 4848 h: irritability, tremor, seizures.

  • Methadone → later onset, more severe NAS; seizures; naloxone contraindicated.

  • Cocaine → stillbirth, asphyxia, prematurity, LBW; breastfeeding contra-indicated.

  • Amphetamine/Meth → ↑ mortality, prematurity, CNS bleeds.

  • Marijuana → no consistent neonatal pattern to date.

Prematurity & Low-Birth-Weight (LBW)

  • Prematurity: birth <37 wk.

  • LBW <2500 g; VLBW <1500 g; ELBW <1000 g.

  • Global prematurity rate 610%6−10\%.

Contributing Factors

Maternal: low SES, preeclampsia, infection (UTI, GBS), chronic illness, drugs.
Fetal: twins, distress, anomalies.
Obstetric: cervical insufficiency, polyhydramnios, chorioamnionitis, PROM, previa, abruption.

Transition Challenges

  • Immature organs, low mass → slower adaptation, low Apgar, resuscitation needs.

  • Thermoregulation: large SA/BW, ↓ brown & subQ fat, immature hypothalamus; prevent via radiant warmer, wrap, minimize evaporative loss.

  • Heat loss modes: conduction, convection, radiation, evaporation.

  • Neutral thermal environment essential until 34\ge34 wk PCA.

Brown Fat
  • Highly thermogenic; located neck, axillae, kidneys, mediastinum; absent/low in preterms.

Glucose Homeostasis
  • Limited glycogen & immature counter-regulation → IV glucose or early enteral feeds.

Respiratory System
  • Surfactant deficiency → RDS; apnea of prematurity (<3434 wk) d/t immature medulla.

  • ROP risk when born <32 wk (retinal vascularization incomplete).

GI/Nutrition
  • Enzymes present, but motility weak; require 120150120−150 kcal/kg/d$ by DOL 7−10.</p></li><li><p>Combinedparenteral+enteral(1020mL/kg/dincrements)usingbreastmilkorpretermformulas.</p></li></ul><h5id="2120c809fc254a3abb24638d5de3fbf6"datatocid="2120c809fc254a3abb24638d5de3fbf6"collapsed="false"seolevelmigrated="true">Hepatic/Bilirubin</h5><ul><li><p>LargerRBCmass,shorterlifespan,lowUGTactivityphysiologicjaundiceearlier(day.</p></li><li><p>Combined parenteral + enteral (10–20 mL/kg/d increments) using breast milk or pre-term formulas.</p></li></ul><h5 id="2120c809-fc25-4a3a-bb24-638d5de3fbf6" data-toc-id="2120c809-fc25-4a3a-bb24-638d5de3fbf6" collapsed="false" seolevelmigrated="true">Hepatic/Bilirubin</h5><ul><li><p>Larger RBC mass, shorter lifespan, low UGT activity → physiologic jaundice earlier (day1−2),peaks), peaks5−7d,resolvesd, resolves ≤14d.</p></li></ul><h5id="10a6459952764f2e96a54e98cddb7c71"datatocid="10a6459952764f2e96a54e98cddb7c71"collapsed="false"seolevelmigrated="true">Cardiovascular</h5><ul><li><p>PDAcommon;closureinverselyrelatedtoGA.</p></li></ul><h5id="27a35dfa03be41ed9e46065275b581ae"datatocid="27a35dfa03be41ed9e46065275b581ae"collapsed="false"seolevelmigrated="true">Immunology</h5><ul><li><p>IgGtransfermainly3rdtrimesterdiminishedpassiveimmunitysepsisrisk.</p></li></ul><h5id="93a1c87b1d7448fe98e381af615c0497"datatocid="93a1c87b1d7448fe98e381af615c0497"collapsed="false"seolevelmigrated="true">Hematology</h5><ul><li><p>Anemiaofprematurityatd.</p></li></ul><h5 id="10a64599-5276-4f2e-96a5-4e98cddb7c71" data-toc-id="10a64599-5276-4f2e-96a5-4e98cddb7c71" collapsed="false" seolevelmigrated="true">Cardiovascular</h5><ul><li><p>PDA common; closure inversely related to GA.</p></li></ul><h5 id="27a35dfa-03be-41ed-9e46-065275b581ae" data-toc-id="27a35dfa-03be-41ed-9e46-065275b581ae" collapsed="false" seolevelmigrated="true">Immunology</h5><ul><li><p>IgG transfer mainly 3rd trimester → diminished passive immunity → ↑ sepsis risk.</p></li></ul><h5 id="93a1c87b-1d74-48fe-98e3-81af615c0497" data-toc-id="93a1c87b-1d74-48fe-98e3-81af615c0497" collapsed="false" seolevelmigrated="true">Hematology</h5><ul><li><p>Anemia of prematurity at6−12wk;lowerironstores.</p></li></ul><h5id="77fb74e964564c6d89f8892ede601d65"datatocid="77fb74e964564c6d89f8892ede601d65"collapsed="false"seolevelmigrated="true">Survival(DevelopedCountries)</h5><ul><li><p>wk; lower iron stores.</p></li></ul><h5 id="77fb74e9-6456-4c6d-89f8-892ede601d65" data-toc-id="77fb74e9-6456-4c6d-89f8-892ede601d65" collapsed="false" seolevelmigrated="true">Survival (Developed Countries)</h5><ul><li><p><500g:g:15\%;;500−750g:g:60\%;;1250−1500g:g:>90\%.</p></li></ul><h3id="e15806be3c18449585116ab9b0d51e4c"datatocid="e15806be3c18449585116ab9b0d51e4c"collapsed="false"seolevelmigrated="true">SizeforGestationalAgeCategories</h3><ul><li><p>SGA:BW.</p></li></ul><h3 id="e15806be-3c18-4495-8511-6ab9b0d51e4c" data-toc-id="e15806be-3c18-4495-8511-6ab9b0d51e4c" collapsed="false" seolevelmigrated="true">Size-for-Gestational-Age Categories</h3><ul><li><p>SGA: BW<10^{th}percentile.Earlysymmetric(insultpercentile. • Early symmetric (insult<28 wk): small HC & length; causes – severe maternal vascular disease, renal disease, anomalies, infection, chromosomal issues. • Late asymmetric (insult >28wk):headsparing;seenwithtwins,preeclampsia.</p></li><li><p>LGA:BWwk): head-sparing; seen with twins, pre-eclampsia.</p></li><li><p>LGA: BW>90^{th}percentile;riskgroupsIDM,postdates,BeckwithWiedemann;macrosomiapercentile; risk groups – IDM, post-dates, Beckwith-Wiedemann; macrosomia>4 kg.

Delivery Room Management & Apgar

  • Suction nose/mouth after head; clamp cord at table level; place under warmer.

  • Tactile stimulation (back rub, foot flick) if needed.

Apgar Scoring

  • 5 parameters (Color, Respiration, HR, Reflex, Tone) 0−2each;assesseach; assess1 & 5min(±min (±(10,15)).</p></li><li><p>Scores:).</p></li><li><p>Scores:8−10normal;normal;4−7needsupport;need support;0−3immediateresus.</p></li><li><p>Notpredictiveoflongtermneurooutcome;neverdelayresusforscoring.</p></li></ul><h3id="39ede6ac7c904267a72f6a702a1392bb"datatocid="39ede6ac7c904267a72f6a702a1392bb"collapsed="false"seolevelmigrated="true">NeonatalResuscitationPrinciples</h3><ul><li><p>Anticipation:immediate resus.</p></li><li><p>Not predictive of long-term neuro-outcome; never delay resus for scoring.</p></li></ul><h3 id="39ede6ac-7c90-4267-a72f-6a702a1392bb" data-toc-id="39ede6ac-7c90-4267-a72f-6a702a1392bb" collapsed="false" seolevelmigrated="true">Neonatal Resuscitation Principles</h3><ul><li><p>Anticipation:10\%needassistance;need assistance;<1\%requireextensivemeasures.</p></li><li><p>Goals:thermalcontrol,airway/breathing,oxygenation,circulation.</p></li><li><p>InitialFiOrequire extensive measures.</p></li><li><p>Goals: thermal control, airway/breathing, oxygenation, circulation.</p></li><li><p>Initial FiO_2:term: term21\%,preterm, pre-term21−30\%.</p></li></ul><h5id="22ab1cba5ecf4b7c8834f51205024ed1"datatocid="22ab1cba5ecf4b7c8834f51205024ed1"collapsed="false"seolevelmigrated="true">Algorithm</h5><ol><li><p>Spontaneousbreath,HR.</p></li></ul><h5 id="22ab1cba-5ecf-4b7c-8834-f51205024ed1" data-toc-id="22ab1cba-5ecf-4b7c-8834-f51205024ed1" collapsed="false" seolevelmigrated="true">Algorithm</h5><ol><li><p>Spontaneous breath, HR>100,pinktactilestimulation.</p></li><li><p>Spontaneous,HR, pink → tactile stimulation.</p></li><li><p>Spontaneous, HR>100,cyanoticblowbyO, cyanotic → blow-by O_2.</p></li><li><p>ApnoeaorHR.</p></li><li><p>Apnoea or HR<100bagmaskventilation.</p></li><li><p>HR→ bag-mask ventilation.</p></li><li><p>HR<100despiteventilationassesstechnique,FiOdespite ventilation → assess technique, ↑ FiO_2toto100\%,intubate±drugs/volume.</p></li></ol><h3id="28528aaa927343e89b086bc08c1d6dea"datatocid="28528aaa927343e89b086bc08c1d6dea"collapsed="false"seolevelmigrated="true">NeonatalSepsis</h3><ul><li><p>Systemicbacterialinfection;incidence, intubate ± drugs/volume.</p></li></ol><h3 id="28528aaa-9273-43e8-9b08-6bc08c1d6dea" data-toc-id="28528aaa-9273-43e8-9b08-6bc08c1d6dea" collapsed="false" seolevelmigrated="true">Neonatal Sepsis</h3><ul><li><p>Systemic bacterial infection; incidence1−5/1000livebirths;VLBWhigher.</p></li><li><p>Earlyonset(EOS)live births; VLBW higher.</p></li><li><p>Early-onset (EOS)<72h(usuallyh (usually<24h):GBS,E.coli,Klebsiella,Listeria;fulminant.</p></li><li><p>Lateonset(LOS)h): GBS, E. coli, Klebsiella, Listeria; fulminant.</p></li><li><p>Late-onset (LOS)>72htoh to90d:communityvsNICU;Gramnegatives(Klebsiella,Enterobacter,Pseudomonas),MRSA,CONS.</p></li></ul><h4id="09e3d79dcd0a40faa905e0a4d4e9d6db"datatocid="09e3d79dcd0a40faa905e0a4d4e9d6db"collapsed="false"seolevelmigrated="true">RiskFactors</h4><ul><li><p>Asphyxia,prematurity,PROMd: community vs NICU; Gram-negatives (Klebsiella, Enterobacter, Pseudomonas), MRSA, CONS.</p></li></ul><h4 id="09e3d79d-cd0a-40fa-a905-e0a4d4e9d6db" data-toc-id="09e3d79d-cd0a-40fa-a905-e0a4d4e9d6db" collapsed="false" seolevelmigrated="true">Risk Factors</h4><ul><li><p>Asphyxia, prematurity, PROM>18h,chorioamnionitis,foulliquor,maternalfever,invasivelines.</p></li></ul><h4id="504486b4a122466494cd3b2f80b44b28"datatocid="504486b4a122466494cd3b2f80b44b28"collapsed="false"seolevelmigrated="true">ClinicalSigns</h4><ul><li><p>Subtle:feedingchange,behavior;laterlethargy,tempinstability,apnea,pallor.</p></li><li><p>Meningitisclues:seizures,bulgingfontanel,highpitchedcry.</p></li></ul><h4id="c7858167eb6b4a889fab91a932795d26"datatocid="c7858167eb6b4a889fab91a932795d26"collapsed="false"seolevelmigrated="true">Workup</h4><ul><li><p>CBC,CRP,PCT,bloodculture,CSF,CXR,urine;gastricaspirateshaketest.</p></li></ul><h4id="1e5496e16ed84eb08be2879bae3f279e"datatocid="1e5496e16ed84eb08be2879bae3f279e"collapsed="false"seolevelmigrated="true">Management</h4><ul><li><p>Empiric:Ampicillinh, chorioamnionitis, foul liquor, maternal fever, invasive lines.</p></li></ul><h4 id="504486b4-a122-4664-94cd-3b2f80b44b28" data-toc-id="504486b4-a122-4664-94cd-3b2f80b44b28" collapsed="false" seolevelmigrated="true">Clinical Signs</h4><ul><li><p>Subtle: feeding change, behavior; later – lethargy, temp instability, apnea, pallor.</p></li><li><p>Meningitis clues: seizures, bulging fontanel, high-pitched cry.</p></li></ul><h4 id="c7858167-eb6b-4a88-9fab-91a932795d26" data-toc-id="c7858167-eb6b-4a88-9fab-91a932795d26" collapsed="false" seolevelmigrated="true">Work-up</h4><ul><li><p>CBC, CRP, PCT, blood culture, CSF, CXR, urine; gastric aspirate shake-test.</p></li></ul><h4 id="1e5496e1-6ed8-4eb0-8be2-879bae3f279e" data-toc-id="1e5496e1-6ed8-4eb0-8be2-879bae3f279e" collapsed="false" seolevelmigrated="true">Management</h4><ul><li><p>Empiric: Ampicillin100−200mg/kg/dmg/kg/d+GentamicinGentamicin5mg/kg/d.</p></li><li><p>Meningitis:doubleβlactamdose;2ndlinecefotaximemg/kg/d.</p></li><li><p>Meningitis: double β-lactam dose; 2nd-line cefotaxime25mg/kgQ812horceftriaxonemg/kg Q8–12 h or ceftriaxone50mg/kg.</p></li><li><p>Duration:suspectedmg/kg.</p></li><li><p>Duration: suspected7d;cultureprovend; culture-proven14d;Gnegmeningitisd; G-neg meningitis21d;bone/jointd; bone/joint4−6wk.</p></li></ul><h4id="27dba4567bac4d66babed67a9a35af21"datatocid="27dba4567bac4d66babed67a9a35af21"collapsed="false"seolevelmigrated="true">Prevention</h4><ul><li><p>Universalprecautions,handhygiene,NICUsanitation,restrictillstaff.</p></li></ul><h3id="139ab5772d9a44aa85058d6fcaf0b81b"datatocid="139ab5772d9a44aa85058d6fcaf0b81b"collapsed="false"seolevelmigrated="true">TORCHESInfections</h3><ul><li><p>Commonlyacquiredwk.</p></li></ul><h4 id="27dba456-7bac-4d66-babe-d67a9a35af21" data-toc-id="27dba456-7bac-4d66-babe-d67a9a35af21" collapsed="false" seolevelmigrated="true">Prevention</h4><ul><li><p>Universal precautions, hand hygiene, NICU sanitation, restrict ill staff.</p></li></ul><h3 id="139ab577-2d9a-44aa-8505-8d6fcaf0b81b" data-toc-id="139ab577-2d9a-44aa-8505-8d6fcaf0b81b" collapsed="false" seolevelmigrated="true">TORCH-ES Infections</h3><ul><li><p>Commonly acquired1^{st}/2^{nd}trimesterIUGR.</p></li></ul><h4id="9d830a6ac926403db4787495f92fcc2b"datatocid="9d830a6ac926403db4787495f92fcc2b"collapsed="false"seolevelmigrated="true">Toxoplasmosis</h4><ul><li><p>Source:undercookedmeat,catfeces.</p></li><li><p>Findings:jaundice,HSM,microcephaly,chorioretinitis,hydrocephalus,ICcalcifications.</p></li><li><p>Tx:Maternalspiramycin;neonatalpyrimethaminetrimester → IUGR.</p></li></ul><h4 id="9d830a6a-c926-403d-b478-7495f92fcc2b" data-toc-id="9d830a6a-c926-403d-b478-7495f92fcc2b" collapsed="false" seolevelmigrated="true">Toxoplasmosis</h4><ul><li><p>Source: undercooked meat, cat feces.</p></li><li><p>Findings: jaundice, HSM, microcephaly, chorioretinitis, hydrocephalus, IC calcifications.</p></li><li><p>Tx: Maternal spiramycin; neonatal pyrimethamine+sulfadiazinesulfadiazine+leucovorin.</p></li></ul><h4id="6597f2d2d492448e8907544fac932b2d"datatocid="6597f2d2d492448e8907544fac932b2d"collapsed="false"seolevelmigrated="true">CongenitalRubella</h4><ul><li><p>Infectionleucovorin.</p></li></ul><h4 id="6597f2d2-d492-448e-8907-544fac932b2d" data-toc-id="6597f2d2-d492-448e-8907-544fac932b2d" collapsed="false" seolevelmigrated="true">Congenital Rubella</h4><ul><li><p>Infection<8 wk GA.

  • Triad: PDA/PS, cataracts, deafness; blueberry-muffin rash.

CMV

  • Primary > reactivation severity.

  • Findings: HSM, jaundice, periventricular calcifications, microcephaly, thrombocytopenia.

HSV

  • Manifestations: skin-eye-mouth (5-14 d), CNS (3-4 wk), disseminated (5-7 d).

  • Tx: IV acyclovir; C-section if active lesions.

Syphilis

  • Early: snuffles, rash, periostitis; Late: Hutchinson teeth, saber shins.

  • Dx: VDRL, FTA-ABS; Tx: penicillin.

Varicella

  • Neonatal if maternal rash −5 to +2 d → give VZIG; congenital limb/scar defects if infection 1st/2nd trimester.

Hypothermia in Neonates

  • Skin <36.5 °C & core <35.5°C.</p></li><li><p>Heatloss:convection,conduction,radiation,evaporation(largestatbirth).</p></li><li><p>Heatproduction:muscleactivity,nonshiveringthermogenesis(brownfat).</p></li><li><p>Hypothermiastages:mild°C.</p></li><li><p>Heat loss: convection, conduction, radiation, evaporation (largest at birth).</p></li><li><p>Heat production: muscle activity, non-shivering thermogenesis (brown fat).</p></li><li><p>Hypothermia stages: mild36−36.4°C,moderate°C, moderate32−35.9°C,severe°C, severe<32 °C.

  • Warm chain: immediate drying, warm resus, skin-to-skin, early breastfeeding, warm transport.

  • Management: KMC, radiant warmer, incubator; beware hyperthermia.

Respiratory Distress & Apnea

  • Distress if ANY: RR >60 bpm, retractions, grunting, central cyanosis.

Etiologies

Pulmonary: RDS, MAS, TTNB, pneumonia, BPD, pulmonary hemorrhage.
Extra-pulmonary: CHD, metabolic (hypoglycemia, acidosis), neuro (seizure, IVH), anemia.

Approach
  • History (GA, steroids, IDM, PROM, labor details).

  • Exam (vitals, meconium, chest shape, scaphoid abdomen, nasal patency).

  • Investigations: CBC, CXR, septic screen, ABG.

  • Management: thermoneutrality, oxygen/CPAP/ventilation, treat cause.

Respiratory Distress Syndrome (HMD)

  • Surfactant deficiency; risk ↑ with ↓ GA (<34wk),IDM,male,2ndtwin,Csection.</p></li><li><p>CXR:lowvolume,groundglass,airbronchograms.</p></li><li><p>Rx:CPAP,exogenoussurfactant,gentleventilation;preventwithantenatalsteroids.</p></li></ul><h4id="b99b76f4be184ff682a5701f4968fa40"datatocid="b99b76f4be184ff682a5701f4968fa40"collapsed="false"seolevelmigrated="true">TTNB</h4><ul><li><p>Delayedfetallungfluidclearance;termCsectionorprecipitousdelivery;CXR:wetlungs,fissurefluid;resolveswk), IDM, male, 2nd twin, C-section.</p></li><li><p>CXR: low volume, ground-glass, air bronchograms.</p></li><li><p>Rx: CPAP, exogenous surfactant, gentle ventilation; prevent with antenatal steroids.</p></li></ul><h4 id="b99b76f4-be18-4ff6-82a5-701f4968fa40" data-toc-id="b99b76f4-be18-4ff6-82a5-701f4968fa40" collapsed="false" seolevelmigrated="true">TTNB</h4><ul><li><p>Delayed fetal lung-fluid clearance; term C-section or precipitous delivery; CXR: wet lungs, fissure fluid; resolves<72h.</p></li></ul><h4id="d2df86cc07264222a91b08e3d14967fe"datatocid="d2df86cc07264222a91b08e3d14967fe"collapsed="false"seolevelmigrated="true">MeconiumAspirationSyndrome</h4><ul><li><p>Occursinh.</p></li></ul><h4 id="d2df86cc-0726-4222-a91b-08e3d14967fe" data-toc-id="d2df86cc-0726-4222-a91b-08e3d14967fe" collapsed="false" seolevelmigrated="true">Meconium Aspiration Syndrome</h4><ul><li><p>Occurs in5\% of meconium-stained deliveries; risk in post-dates, placental dysfunction.

  • Pathophys: airway obstruction, chemical pneumonitis.

  • Prevention: avoid fetal hypoxia; tracheal suction only if depressed & thick MEC.

Congenital Diaphragmatic Hernia

  • Bowel in thorax → pulmonary hypoplasia; scaphoid abdomen; intubate immediately, surgical repair when stable.

Apnea of Prematurity

  • Central, obstructive, mixed; ↑ incidence with ↓ GA.

  • Treat underlying cause, caffeine or aminophylline, CPAP/ventilation.

Perinatal Asphyxia & Hypoxic-Ischemic Encephalopathy (HIE)

  • Impaired gas exchange → fetal acidosis, hypoxemia, hypercarbia.

  • Incidence 1−1.5\% live births; higher in <36wk.</p></li></ul><h4id="f630ad3741a1403f9618e1a06e7eab7b"datatocid="f630ad3741a1403f9618e1a06e7eab7b"collapsed="false"seolevelmigrated="true">Timing</h4><ul><li><p>Antepartum(placentalinsufficiency),intrapartum(cordprolapse,abruption),postnatal(PPHN,shock).</p></li></ul><h4id="4ae20ffe60e249538828318cd22c4a94"datatocid="4ae20ffe60e249538828318cd22c4a94"collapsed="false"seolevelmigrated="true">Pathophysiology</h4><ul><li><p>PrimaryapnearespondstoOwk.</p></li></ul><h4 id="f630ad37-41a1-403f-9618-e1a06e7eab7b" data-toc-id="f630ad37-41a1-403f-9618-e1a06e7eab7b" collapsed="false" seolevelmigrated="true">Timing</h4><ul><li><p>Antepartum (placental insufficiency), intrapartum (cord prolapse, abruption), post-natal (PPHN, shock).</p></li></ul><h4 id="4ae20ffe-60e2-4953-8828-318cd22c4a94" data-toc-id="4ae20ffe-60e2-4953-8828-318cd22c4a94" collapsed="false" seolevelmigrated="true">Pathophysiology</h4><ul><li><p>Primary apnea → responds to O_2/stim;secondaryapneaneedsPPV.</p></li><li><p>Divingreflex:bloodtoheart/brainmultiorganischemia(kidney/stim; secondary apnea → needs PPV.</p></li><li><p>Diving reflex: blood to heart/brain → multiorgan ischemia (kidney50\%,CNS, CNS28\%,CVS, CVS25\%,lungs, lungs23\%).

Diagnosis

  • Prolonged acidosis, FHR <60, Apgar <3atat10min,seizuresmin, seizures<24h,EEGabnormalities.</p></li></ul><h4id="b586d2aaba1943cca566659164b2bdb8"datatocid="b586d2aaba1943cca566659164b2bdb8"collapsed="false"seolevelmigrated="true">SarnatStaging</h4><ul><li><p>StageI(mild):hyperalert;goodprognosis.</p></li><li><p>StageII(mod):lethargy,hypotonia,seizures;h, EEG abnormalities.</p></li></ul><h4 id="b586d2aa-ba19-43cc-a566-659164b2bdb8" data-toc-id="b586d2aa-ba19-43cc-a566-659164b2bdb8" collapsed="false" seolevelmigrated="true">Sarnat Staging</h4><ul><li><p>Stage I (mild): hyperalert; good prognosis.</p></li><li><p>Stage II (mod): lethargy, hypotonia, seizures;\approx80\%normal.</p></li><li><p>StageIII(severe):coma,flaccid,absentreflexes;normal.</p></li><li><p>Stage III (severe): coma, flaccid, absent reflexes;50\%death,death,50\%majordeficits.</p></li></ul><h4id="2455b28c2704404fad24201977102045"datatocid="2455b28c2704404fad24201977102045"collapsed="false"seolevelmigrated="true">Management</h4><ul><li><p>Anticipate;avoidBPfluctuations;restrictIVFmajor deficits.</p></li></ul><h4 id="2455b28c-2704-404f-ad24-201977102045" data-toc-id="2455b28c-2704-404f-ad24-201977102045" collapsed="false" seolevelmigrated="true">Management</h4><ul><li><p>Anticipate; avoid BP fluctuations; restrict IVF\tfrac23maintenance;correctacidosis;controlseizures(phenobarbitalfirstline).</p></li><li><p>Therapeutichypothermia(selectiveheadorwholebodymaintenance; correct acidosis; control seizures (phenobarbital first-line).</p></li><li><p>Therapeutic hypothermia (selective head or whole body33−34°C×°C ×72h)onlyprovenneuroprotection.</p></li><li><p>Prevention:qualityantenatalsurveillance,intrapartummonitoring,timelyresuscitation.</p></li></ul><h3id="5f52a1fefb02415f8711e5c9bc313965"datatocid="5f52a1fefb02415f8711e5c9bc313965"collapsed="false"seolevelmigrated="true">NeonatalSeizures</h3><ul><li><p>Occurinh) – only proven neuroprotection.</p></li><li><p>Prevention: quality antenatal surveillance, intrapartum monitoring, timely resuscitation.</p></li></ul><h3 id="5f52a1fe-fb02-415f-8711-e5c9bc313965" data-toc-id="5f52a1fe-fb02-415f-8711-e5c9bc313965" collapsed="false" seolevelmigrated="true">Neonatal Seizures</h3><ul><li><p>Occur in\le50\%ofHIEsurvivors;indicatemoderatesevereencephalopathy.</p></li></ul><h4id="467d0efd177c48d7ab8dd84b90eabd55"datatocid="467d0efd177c48d7ab8dd84b90eabd55"collapsed="false"seolevelmigrated="true">Types</h4><ol><li><p>Subtle(oculardeviation,chewing).2.Clonic.3.Tonic.4.Myoclonic.5.Spasms.</p></li></ol><h4id="d92ecd48bdfe478797fe852d76af657a"datatocid="d92ecd48bdfe478797fe852d76af657a"collapsed="false"seolevelmigrated="true">CausesbyAge</h4><p>Dayof HIE survivors; indicate moderate-severe encephalopathy.</p></li></ul><h4 id="467d0efd-177c-48d7-ab8d-d84b90eabd55" data-toc-id="467d0efd-177c-48d7-ab8d-d84b90eabd55" collapsed="false" seolevelmigrated="true">Types</h4><ol><li><p>Subtle (ocular deviation, chewing). 2. Clonic. 3. Tonic. 4. Myoclonic. 5. Spasms.</p></li></ol><h4 id="d92ecd48-bdfe-4787-97fe-852d76af657a" data-toc-id="d92ecd48-bdfe-4787-97fe-852d76af657a" collapsed="false" seolevelmigrated="true">Causes by Age</h4><p>Day1−4:HIE,IVH,metabolic,drugtoxicity.<br>Day: HIE, IVH, metabolic, drug toxicity.<br>Day4−14:infection,metab,benignfamilialconvulsion,kernicterus.<br>Week: infection, metab, benign familial convulsion, kernicterus.<br>Week2−8: infection, trauma, cortical malformations.

    Diagnosis & Tx

    • EEG gold standard. Labs: glucose, Ca^{2+},Mg, Mg^{2+},Na, Na^+.</p></li><li><p>Firstlinephenobarbital.</p></li><li><p>First-line phenobarbital20mg/kg(uptomg/kg (up to40mg/kg).Ifrefractoryphenytoinmg/kg). If refractory → phenytoin15−20mg/kg(ratemg/kg (rate0.5−1mg/kg/min).Benzos(lorazepam)foracutecontrol.</p></li><li><p>DiscontinueAEDsifseizurefreemg/kg/min). Benzos (lorazepam) for acute control.</p></li><li><p>Discontinue AEDs if seizure-free>2−3 mo & etiology benign; individualize.

    Neonatal Jaundice

    • Visible when scleral >20 mg/dL or skin >5mg/dL.</p></li><li><p>Occursinmg/dL.</p></li><li><p>Occurs in60\% term & 80\%preterm;significantinpre-term; significant in6\% term.

    Physiology

    • ↑ RBC mass & turnover; immature ligandin & UDP-GT; sterile gut ↑ β-glucuronidase.

    • Term: peak 5−6mg/dLonDOLmg/dL on DOL2−4;resolvesbyDOL; resolves by DOL5−7.</p></li><li><p>Preterm:peak.</p></li><li><p>Preterm: peak8−12mg/dLonDOLmg/dL on DOL4−7;resolvesbyDOL; resolves by DOL<10.</p></li></ul><h4id="bd1b81118be7479ca1001d2e2ad92032"datatocid="bd1b81118be7479ca1001d2e2ad92032"collapsed="false"seolevelmigrated="true">BreastFeedingJaundice(early)</h4><ul><li><p>intake,dehydration;onsetwithinfirstweek;managebyfrequentfeeding.</p></li></ul><h4id="92ea6b06a4f147c2b4690380e27a72bb"datatocid="92ea6b06a4f147c2b4690380e27a72bb"collapsed="false"seolevelmigrated="true">BreastMilkJaundice(late)</h4><ul><li><p>βglucuronidaseinmilk;onsetafterweek1;mayreach.</p></li></ul><h4 id="bd1b8111-8be7-479c-a100-1d2e2ad92032" data-toc-id="bd1b8111-8be7-479c-a100-1d2e2ad92032" collapsed="false" seolevelmigrated="true">Breast-Feeding Jaundice (early)</h4><ul><li><p>↓ intake, dehydration; onset within first week; manage by frequent feeding.</p></li></ul><h4 id="92ea6b06-a4f1-47c2-b469-0380e27a72bb" data-toc-id="92ea6b06-a4f1-47c2-b469-0380e27a72bb" collapsed="false" seolevelmigrated="true">Breast-Milk Jaundice (late)</h4><ul><li><p>β-glucuronidase in milk; onset after week 1; may reach10−30mg/dL;temporaryinterruptionmg/dL; temporary interruption2−3difneeded.</p></li></ul><h4id="f323e8c1ae6446239357fb4955d54da9"datatocid="f323e8c1ae6446239357fb4955d54da9"collapsed="false"seolevelmigrated="true">PathologicIndicators</h4><ul><li><p>Onsetd if needed.</p></li></ul><h4 id="f323e8c1-ae64-4623-9357-fb4955d54da9" data-toc-id="f323e8c1-ae64-4623-9357-fb4955d54da9" collapsed="false" seolevelmigrated="true">Pathologic Indicators</h4><ul><li><p>Onset<24h,riseh, rise>5 mg/dL/day, TSB >12mg/dLmg/dL (term) //>15mg/dLmg/dL (preterm), conjugated >1.51.5 mg/dL or >20\% of TSB, duration >11 wk (term) or 22 wk (preterm).

    Hemolytic Disease
    • Rh(D) (severe) vs ABO (common, mild). Direct Coombs +. Treat with phototherapy, exchange transfusion if criteria met.

    Treatment Modalities

    • Phototherapy: blue-green light converts bilirubin to lumirubin & polar photoisomers → renal excretion. Initiate earlier in <35 wk or BW <2 kg.

    • Exchange transfusion: double-volume 170170 mL/kg when TSB exceeds thresholds despite intensive phototherapy or with hydrops/falling Hb.

    Complications of Exchange
    • Metabolic (hypoCa2+^{2+}, hypoMg2+^{2+}, hyperK+^+, hypoglycemia), NEC, infection, arrhythmia.

    Kernicterus

    • Bilirubin deposition in basal ganglia, hippocampus, sub-thalamus, cerebellum.

    • Risk factors: prematurity, acidosis, hypoxia, hypoglycemia, hypoalbuminemia, sepsis.

    • Stages: I (lethargy, poor suck), II (opisthotonus, seizures), III (spasticity ↓), IV (long-term – CP, hearing loss).

    Birth Injuries

    Intracranial

    • Preterm: IVH; Term: subdural hemorrhage.

    • Manifestations: RD, pallor, seizures, unequal pupils → CT/US.

    Spinal Cord

    • Difficult delivery; complete vs partial transection vs compression.

    Peripheral Nerves

    • Brachial plexus: Erb (C565−6) absent Moro, waiter's-tip; Klumpke (C7T17−T1) hand paralysis ± Horner.

    • Phrenic (C44) → diaphragmatic paralysis.

    • Facial (CN VII) palsy from forceps.

    Skeletal/Visceral

    • Clavicle fracture esp with shoulder dystocia; manage with immobilization.

    • Liver laceration & bleed in breech.

    GI: Necrotizing Enterocolitis (NEC)

    • Prematurity largest risk; bowel ischemia + bacterial invasion → transmural necrosis.

    • S/S: feeding intolerance, abdominal distention, bloody stools, apnea.

    • XR: pneumatosis intestinalis, fixed loops, portal venous gas, free air.

    • Tx: NPO, NG decompression, IV fluids, broad antibiotics; surgery for perforation/necrosis.

    • Sequelae: strictures, malabsorption, SBS.

    Hematologic Disorders

    Anemia

    • Causes: hemolysis, acute blood loss, nutritional deficiency.

    • Tx: PRBC 1010 mL/kg, vit K (HDN), vit E/iron, EPO if indicated.

    Polycythemia (Hct >65\%)

    • Causes: placental insufficiency (SGA), delayed cord clamping, twin-twin or maternal-fetal transfusion, CAH, IDM.

    • Symptoms: lethargy, poor feeding, cyanosis, RD.

    • Complications: hyperbili, thrombosis, PPHN.

    • Tx: partial exchange transfusion.

    Endocrine Disorders

    Infant of Diabetic Mother (IDM)

    • Fetal hyperinsulinism → macrosomia (spares brain), plethoric, hypoglycemia (tremor, apnea), polycythemia, hypocalcemia, RDS.

    • Cardiac: asymmetric septal hypertrophy, VSD, TGA.

    • Tx: early feeds, D1010W 22 mL/kg bolus if glucose low.

    Congenital Hypothyroidism

    • Large fontanel, macroglossia, umbilical hernia, prolonged jaundice.

    • Screen T4 & TSH; treat with levothyroxine 5105−10 µg/kg/d.

    Congenital Adrenal Hyperplasia (CAH)

    • Autosomal recessive enzyme defects (mostly 21-hydroxylase).

    • Classic salt-wasting (70-75%\%): crisis at <2 wk (↓Na+^+, ↑K+^+, shock).

    • Simple virilizing: androgen excess without salt loss.

    • Nonclassic: late onset (hirsutism, early puberty).

    • Females: ambiguous genitalia; males often normal externally.

    • Dx: ↑ 17-OH-progesterone (newborn screen), electrolytes, ACTH, androgens, karyotype, pelvic US.

    • Tx: hydrocortisone, fludrocortisone & Na+^+ supp (salt-losers), surgical correction of genitalia.

    Hypothermia Management Methods

    1. Kangaroo Mother Care (skin-to-skin).

    2. Radiant warmer (servo control).

    3. Incubator (humidified warm air).

    • Monitor for hyperthermia, hidden infection, dehydration.

    Key Numerical & Formula References (LaTeX)

    • Phototherapy initiation threshold depends on GA & risk: e.g., TSB > (5 + 5 \times \text{day})\,\text{mg/dL} (illustrative—follow unit protocols).

    • Exchange transfusion volume: V=2×BWkg×85mLV = 2 \times BW_{kg} \times 85\,mL (double-volume).

    • Glucose infusion rate goal in preterm: 46mgkg1min14−6\,mg\,kg^{-1}\,min^{-1}.

    Ethical & Practical Connections

    • Balancing maternal vs fetal indications for delivery (preeclampsia, diabetes) highlights autonomy vs beneficence.

    • Use of antenatal steroids and delayed cord clamping shows evidence-based practice evolution.

    • Resource-limited settings: warm chain, infection prevention, and WHO Essential Newborn Care strategies reduce mortality without high tech.

    Cross-Lecture Links & Real-World Relevance

    • Immunology of prematurity ties into vaccine scheduling & infection prophylaxis.

    • HIE management integrates neurophysiology (cooling) with long-term neuro-developmental follow-up.

    • Jaundice management overlaps with pharmacology (drug displacement of bilirubin) and genetics (G6PD deficiency prevalence in certain populations).

    Summary Checklist for Exams

    • Define high-risk pregnancy and list ante-/intrapartum factors.

    • Recall surfactant physiology, RDS CXR, and therapy.

    • Calculate Apgar, interpret, and outline NRP steps.

    • Distinguish EOS vs LOS sepsis organisms & treatment durations.

    • Identify Sarnat stages and management of HIE including hypothermia window.

    • Apply TSB thresholds for phototherapy/exchange in term vs pre-term.

    • Recognize ambiguous genitalia algorithm and CAH management.

    • List NEC radiographic signs and initial management bundle.

    End of comprehensive study notes.